Genpact Ltd [G] stock prices are down -0.72% to $38.73 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The G shares have gain 1.04% over the last week, with a monthly amount drifted -1.00%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Genpact Ltd [NYSE: G] stock has seen the most recent analyst activity on July 17, 2024, when JP Morgan upgraded its rating to a Neutral and also revised its price target to $40 from $43. Previously, Mizuho started tracking the stock with Neutral rating on January 30, 2024, and set its price target to $40. On December 15, 2023, downgrade downgraded it’s rating to Neutral but maintained its price target of $38 on the stock. JP Morgan downgraded its rating to a Underweight but stick to its price target of $40 on August 22, 2023. Citigroup downgraded its rating to a Neutral and reduced its price target to $42 on July 18, 2023. JP Morgan downgraded its rating to Neutral for this stock on December 15, 2022, and downed its price target to $50. In a note dated February 14, 2022, Cowen downgraded an Market Perform rating on this stock and revised its target price from $57 to $51.
The stock price of Genpact Ltd [G] has been fluctuating between $29.41 and $39.95 over the past year. Currently, Wall Street analysts expect the stock to reach $41.67 within the next 12 months. Genpact Ltd [NYSE: G] shares were valued at $38.73 at the most recent close of the market. An investor can expect a potential return of 7.59% based on the average G price forecast.
Analyzing the G fundamentals
The Genpact Ltd [NYSE:G] reported sales of 4.59B for trailing twelve months, representing a surge of 6.40%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.29 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.42 points at the first support level, and at 38.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.10, and for the 2nd resistance point, it is at 39.46.
Ratios To Look Out For
It’s worth pointing out that Genpact Ltd [NYSE:G]’s Current Ratio is 1.89. In addition, the Quick Ratio stands at 1.89 and the Cash Ratio stands at 0.76. Considering the valuation of this stock, the price to sales ratio is 1.50, the price to book ratio is 2.95 and price to earnings (TTM) ratio is 10.92.
Transactions by insiders
Recent insider trading involved Kalra Balkrishan, President and CEO, that happened on Sep 12 ’24 when 7000.0 shares were sold. Officer, Kalra Balkrishan completed a deal on Sep 12 ’24 to buy 7000.0 shares. Meanwhile, Chief Accounting Officer Klunk Donald J sold 800.0 shares on Aug 14 ’24.
